N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275

Michael Siu(University of California San Diego), Jennifer E. Vogel(Pfizer (United States)), Amy LaPaglia(Pfizer (United States)), Natilie Hosea(University of British Columbia), Thomas Pauly(Pfizer (United States)), Martin P. Edwards(Pfizer (United States)), Arturo Castro(Pfizer (United States)), Jean Matthews(Pfizer (United States)), Theodore Johnson(Pfizer (United States)), Stephan J. Cripps(Pfizer (United States)), Andrea Fanjul(Pfizer (United States)), Jacques Ermolieff(Pfizer (United States)), Yong Wang(Jinan University), Wendy Taylor(Pfizer (United States)), Sajiv K. Nair(Pfizer (United States))
Bioorganic & Medicinal Chemistry Letters
May 8, 2009
10.1016/j.bmcl.2009.05.011
Cited by 45

Related Papers

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
|Journal of Medicinal Chemistry|2011|924
Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
|Journal of Medicinal Chemistry|2014|587
Using the Golden Triangle to optimize clearance and oral absorption
|Bioorganic & Medicinal Chemistry Letters|2009|382
Calcium phosphate-bearing matrices induce osteogenic differentiation of stem cells through adenosine signaling
|Proceedings of the National Academy of Sciences|2014|351
Lipophilic Efficiency as an Important Metric in Drug Design
|Journal of Medicinal Chemistry|2018|340